Endometrial Carcinoma
About
Mappings
NCI Thesaurus: Endometrial Carcinoma (coding:ncit:C7558)
OncoTree: Endometrial Carcinoma (coding:oncotree:UCEC)
Therapeutic response
Precision oncology relationships for therapeutic response involving this cancer type.
Organizations
Biomarkers
Cancer types
Therapies
| Organizations | Biomarkers | Cancer types | Therapies | |
|---|---|---|---|---|
| FDA (2) | dMMR | Endometrial Carcinoma | Carboplatin, Dostarlimab, Paclitaxel | |
| FDA (2) | MSI-H | Endometrial Carcinoma | Carboplatin, Dostarlimab, Paclitaxel | |
| FDA (2) HC (1) | dMMR | Endometrial Carcinoma | Dostarlimab | |
| FDA (2) HC (1) | dMMR | Endometrial Carcinoma | Carboplatin, Durvalumab, Paclitaxel | |
| FDA (2) | MSI-L | Endometrial Carcinoma | Lenvatinib, Pembrolizumab | |
| FDA (2) | pMMR | Endometrial Carcinoma | Pembrolizumab | |
| FDA (2) | MSI-H | Endometrial Carcinoma | Pembrolizumab | |
| HC (1) | MSI-H | Endometrial Carcinoma | Dostarlimab |